Über uns
Dr Fahad Ibnshamsah is a highly respected Consultant Medical Oncologist and Internal Medicine Specialist. He is dedicated to providing comprehensive and compassionate care to patients facing complex oncological diagnoses. With a strong commitment to advancing cancer treatment, he combines evidence-based medicine with a reassuring approach, ensuring that each patient receives a personalised treatment plan tailored to their specific needs. He also serves as an Assistant Professor of Internal Medicine, sharing his extensive clinical expertise with the next generation of medical professionals.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Fahad Ibnshamsah
Ausbildung & Training
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Onkologie
Karriere & Anstellungen
-
2021-09–2022-08 Junior consultant
Lizenzen & Versicherung
Medizinische Lizenzen
SA — Organización Médica Colegial de España (OMC)
Facharztzertifikate
European Board of Onkologie
Berufshaftpflichtversicherung:
HDI Global · 3,000,000 EUR Deckung · No claims on file
Durchgeführte Verfahren
| Verfahren | Code | Lebenszeit-Anzahl |
|---|---|---|
| GP consultation | 99213 | 956 |
| Annual physical exam | 99395 | 266 |
| Vaccination administration | 90471 | 2,826 |
| Minor procedure (skin) | 17110 | 693 |
Leistungen & Preise
| Leistung | Dauer | Modalität | Preis |
|---|---|---|---|
| New patient consultation (60m) | 60 Min. | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 Min. | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 Min. | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 30 Min. | in_clinic | 180.00 EUR |
Praxis, Team & in der Praxis
Videos
Forschung & Publikationen
h-Index: 5 · i10: 7
-
Long-term follow-up of Onkologie across SA
DOI: 10.8710/euroclin.2026.0 · PMID: 37979660 · zitiert von 180
-
Validation of clinical scoring in Onkologie
DOI: 10.5738/euroclin.2025.1 · PMID: 31282003 · zitiert von 102
-
Long-term follow-up of Onkologie across SA
DOI: 10.9519/euroclin.2024.2 · PMID: 33838956 · zitiert von 16
-
Validation of clinical scoring in Onkologie
DOI: 10.4283/euroclin.2023.3 · PMID: 39972240 · zitiert von 162
Eingeladene Vorträge
- Practical updates in Onkologie European Annual Congress (Onkologie) · Vienna · 2024 · invited
- Single-centre experience in Onkologie National Society Meeting · Dammam · 2023 · oral abstract
Auszeichnungen & Mitgliedschaften
Auszeichnungen
- 🏆 Top-rated Onkologie — Dammam · EuroClinics Patient Choice · 2025 · regional
Gesellschaftsmitgliedschaften
- WONCA Europe — Family Doctors — Member · Seit 2022
- national college of family doctors — Member · Seit 2022
- European Union of Medical Specialists (UEMS) — Member · Seit 2022
Artikel dieses Arztes
- Patient education Patient guide to Onkologie
- Awareness When should you see a onkologie?
Für internationale Patienten
- Koordinator
- Patient liaison · fahad.ibnshamsah@euroclinics.example
Standort
1 TagPatientenbewertungen
Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
Aktuelle Bewertungen
-
★★★★★ ✓ Verifiziert Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verifiziert Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verifiziert Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.